文献速递复苏、休克与脓毒症呼吸衰竭与机械通气重症综合管理与镇静镇痛

危重症患者气管插管围术期心血管崩溃:INTUBE研究启示

Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study.
PubMed 文献 · Am J Respir Crit Care Med · 2022-01-01
一句话结论危重症患者气管插管围术期心血管不稳定/崩溃发生率为43.4%,与ICU死亡率升高相关(校正OR 2.47),丙泊酚诱导是与该事件独立相关的可干预因素(OR 1.23)。

INTUBE是一项多中心前瞻性队列研究,纳入29个国家197个中心共2760例接受气管插管的危重症患者。围术期心血管不稳定/崩溃(收缩压<65 mmHg一次或<90 mmHg持续>30分钟、新发/增加血管升压药需求、液体负荷>15 ml/kg或心脏骤停)发生于1199/2760例(43.4%)。多因素分析显示年龄较大、心率较高、收缩压较低、诱导前SpO2/FiO2较低及使用丙泊酚诱导与事件相关;逆概率治疗加权法显示丙泊酚是唯一独立相关因素(OR 1.23)。发生该事件者ICU死亡风险升高(校正OR 2.47,95%CI 1.72-3.55,P<0.001)。

要点

  • 围术期心血管不稳定/崩溃定义为收缩压<65 mmHg一次或<90 mmHg持续>30分钟、新发/增加血管升压药需求、液体负荷>15 ml/kg或心脏骤停,发生率43.4%(1199/2760)。
  • 发生围术期心血管不稳定/崩溃者ICU死亡风险升高,校正OR 2.47(95%CI 1.72-3.55),P<0.001。
  • 逆概率治疗加权法显示丙泊酚诱导是唯一与心血管不稳定/崩溃独立相关的因素(OR 1.23,95%CI 1.02-1.49)。
  • 诱导前给予血管升压药(OR 1.33,95%CI 0.84-2.11)或液体负荷(OR 1.17,95%CI 0.96-1.44)未降低心血管不稳定/崩溃发生率。
  • 多因素分析中与事件相关的变量包括年龄较大(OR 1.02,95%CI 1.02-1.03)、心率较高(OR 1.008,95%CI 1.004-1.012)、收缩压较低(OR 0.98,95%CI 0.98-0.99)、诱导前SpO2/FiO2较低(OR 0.998,95%CI 0.997-0.999)及丙泊酚诱导(OR 1.28,95%CI 1.05-1.57)。

适用人群与场景

  • 危重症接受气管插管的患者,来自29个国家197个中心的前瞻性队列,2018年10月1日至2019年7月31日纳入。

诊断标准与关键阈值

  • 围术期心血管不稳定/崩溃定义:收缩压<65 mmHg一次或<90 mmHg持续>30分钟;新发/增加血管升压药需求;液体负荷>15 ml/kg;或心脏骤停。

研究设计与关键结果

  • 多中心前瞻性队列研究,纳入2760例危重症气管插管患者,围术期心血管不稳定/崩溃发生1199/2760例(43.4%)。
  • 多因素分析显示与事件相关的变量:年龄较大(OR 1.02,95%CI 1.02-1.03)、心率较高(OR 1.008,95%CI 1.004-1.012)、收缩压较低(OR 0.98,95%CI 0.98-0.99)、诱导前SpO2/FiO2较低(OR 0.998,95%CI 0.997-0.999)、丙泊酚诱导(OR 1.28,95%CI 1.05-1.57)。
  • 发生围术期心血管不稳定/崩溃者ICU死亡风险升高,校正OR 2.47(95%CI 1.72-3.55),P<0.001。
  • 逆概率治疗加权法显示丙泊酚是唯一与心血管不稳定/崩溃独立相关的因素(OR 1.23,95%CI 1.02-1.49)。
  • 诱导前给予血管升压药(OR 1.33,95%CI 0.84-2.11)或液体负荷(OR 1.17,95%CI 0.96-1.44)未降低心血管不稳定/崩溃发生率。

证据类型、等级与局限

  • 证据类型:多中心前瞻性队列研究(INTUBE,NCT03616054)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为丙泊酚诱导是与围术期心血管不稳定/崩溃独立相关的可干预因素(OR 1.23,95%CI 1.02-1.49),提示选择诱导药物时需考虑此关联。
  • 诱导前给予血管升压药或液体负荷未降低心血管不稳定/崩溃发生率(血管升压药OR 1.33,95%CI 0.84-2.11;液体负荷OR 1.17,95%CI 0.96-1.44)。

指南或共识出处

  • INTUBE研究(International Observational Study to Understand the Impact and Best Practices of Airway Management In Critically Ill Patients),发表于Am J Respir Crit Care Med,临床试验注册号NCT03616054。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Rationale: Cardiovascular instability/collapse is a common peri-intubation event in patients who are critically ill. Objectives: To identify potentially modifiable variables associated with peri-intubation cardiovascular instability/collapse (i.e., systolic arterial pressure <65 mm Hg [once] or <90 mm Hg for >30 minutes; new/increased vasopressor requirement; fluid bolus >15 ml/kg, or cardiac arrest). Methods: INTUBE (International Observational Study to Understand the Impact and Best Practices of Airway Management In Critically Ill Patients) was a multicenter prospective cohort study of patients who were critically ill and undergoing tracheal intubation in a convenience sample of 197 sites from 29 countries across five continents from October 1, 2018, to July 31, 2019. Measurements and Main Results: A total of 2,760 patients were included in this analysis. Peri-intubation cardiovascular instability/collapse occurred in 1,199 out of 2,760 patients (43.4%). Variables associated with this event were older age (odds ratio [OR], 1.02; 95% confidence interval [CI], 1.02-1.03), higher heart rate (OR, 1.008; 95% CI, 1.004-1.012), lower systolic blood pressure (OR, 0.98; 95% CI, 0.98-0.99), lower oxygen saturation as measured by pulse oximetry/FiO2 before induction (OR, 0.998; 95% CI, 0.997-0.999), and the use of propofol as an induction agent (OR, 1.28; 95% CI, 1.05-1.57). Patients with peri-intubation cardiovascular instability/collapse were at a higher risk of ICU mortality with an adjusted OR of 2.47 (95% CI, 1.72-3.55), P < 0.001. The inverse probability of treatment weighting method identified the use of propofol as the only factor independently associated with cardiovascular instability/collapse (OR, 1.23; 95% CI, 1.02-1.49). When administered before induction, vasopressors (OR, 1.33; 95% CI, 0.84-2.11) or fluid boluses (OR, 1.17; 95% CI, 0.96-1.44) did not reduce the incidence of cardiovascular instability/collapse. Conclusions: Peri-intubation cardiovascular instability/collapse was associated with an increased risk of both ICU and 28-day mortality. The use of propofol for induction was identified as a modifiable intervention significantly associated with cardiovascular instability/collapse.Clinical trial registered with clinicaltrials.gov (NCT03616054).

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Russotto V, Tassistro E, Myatra SN, et al. Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study. Am J Respir Crit Care Med. 2022. PMID: 35536310. doi:10.1164/rccm.202111-2575OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。